Abstract

PostScription: Commentary: Discussion on the Safety of Topical Prilocaine

Author(s): Bramwell Bethany L

Issue: Mar/Apr 2011 - Volume 15, Number 2

Page(s): 174-175

Download in electronic PDF format for $75
  • PostScription: Commentary: Discussion on the Safety of Topical Prilocaine Page 1
  • PostScription: Commentary: Discussion on the Safety of Topical Prilocaine Page 2

Abstract

Related Keywords

  • prilocaine
  • topical preparation
  • drug safety
  • glucose-6-phosphate dehydrogenase
  • G6PD deficiency
  • adverse effects

Related Categories

  • PAIN MANAGEMENT
  • ADVERSE DRUG EVENTS
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2011
Pg. 174-175
PostScription: Commentary: Discussion on the Safety of Topical Prilocaine
Author(s): Bramwell Bethany L
Nov/Dec 2020
Pg. 451-458
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Mar/Apr 2016
Pg. 107-113
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Author(s): Rabi Joseph
Jul/Aug 2020
Pg. 270-276
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Sep/Oct 2020
Pg. 356
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 438-439
PostScription: Compounders Go Above and Beyond in the Name of Safety
Author(s): Gates Ernest P Jr
Sep/Oct 2020
Pg. 371-379
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Mar/Apr 2021
Pg. 146-155
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Mar/Apr 2003
Pg. 94-99
Panel Discussion: Prohormones
Author(s): Ford Peter R, Pylant Phil, Roentsch George
May/Jun 2013
Pg. 182-190
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists
Author(s): Mixon Bill, Nain John
Mar/Apr 2017
Pg. 118-124
Quality Control: (Material) Safety Data Sheets
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 358-360
Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Author(s): Biundo Bruce
Jul/Aug 2014
Pg. 270-276
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Author(s): Johnson Kain, Sully Andrew, Anthenat Bruce
Nov/Dec 2020
Pg. 446-448
NASEM Report on Compounded Topical Pain Creams
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 287-295
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
Author(s): McElhiney Linda F
Nov/Dec 2013
Pg. 485-489
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety
Author(s): Prince Bryan, Lundeval Jeremy
Jul/Aug 2012
Pg. 350-351
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Author(s): Allen Loyd V Jr, Williams LaVonn A